@article{levesque:hal-04534270,
TITLE = {Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients},
AUTHOR = {L{\'e}vesque, H and Viallard, J. F. and Houivet, E and Bonnotte, B and Voisin, S and Le Cam-Duchez, V and Maillot, F and Lambert, M and Liozon, E and Hervier, B. and Fain, O and Guillet, B and Schmidt, J and Luca, L E and Ebbo, M and Ferreira-Maldent, N and Babuty, A and Sailler, L and Duffau, P and Barbay, V and Audia, S and Benichou, J and Graveleau, J and Benhamou, Y},
URL = {https://hal.science/hal-04534270},
JOURNAL = {Thrombosis Research},
PUBLISHER = {Elsevier},
VOLUME = {237},
PAGES = {79-87},
YEAR = {2024},
MONTH = Mar, DOI = {10.1016/j.thromres.2024.03.012},
KEYWORDS = {Acquired hemophilia ; Cyclophosphamide ; Randomized trial ; Rituximab},
HAL_ID = {hal-04534270},
HAL_VERSION = {v1},
}